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Abstract 
BACKGROUND: People co-evolved with members of the microbiota and developed, used and adapted many 
complex immune mechanisms, which are used for monitoring and control of the microbiota. The gut microbiota in 
cooperation with humans became its essential part, so-called "hidden organ" with many important and 
indispensable functions. Quantitative and/or qualitative deficiency of the gut microbiota (dysbiosis) probably is a 
basis of many disorders, including obesity. 
AIM: To present an overview of the possible association between gut microbiota and obesity. 
METHODS: Meta-analysis of available scientific and published data including PubMed, Web of Science, Scopus 
and Cochrane Library. 
RESULTS: In the intestinal microbiota at obese people is detected a specific increase in the proportion between 
class Firmicutes and Bacteroidetes despite the non-obese people. Also, it is detected a decrease in this 
proportion if the person lost weight. These facts may be secondary to obesity. The colonisation of germ-free mice 
with microbiota from ordinarily feed or obese mice, without changes in the feed style leads to increase body fat to 
more than 50%. 
CONCLUSION: The human gut microbiota directly affects the food digestion, absorption and metabolism. The gut 
microbiota of obese people has a higher capacity for receiving energy from the food than the microbiota at slim 
people. The gut microbiota affects appetite control and energy balance. Lifestyle and food regimen affect the 
diversity of the gut microbiota and the presence of dysbiosis.  
 
 
 
 
Introduction 
 
 Malnutrition is a wide term, which embraces 
obesity and undernutrition and is featuring with an 
imbalance between energy input and output. In 2014 
in the World, more than 600 million were obese [1]. 
Obesity is a condition with excess body fat and 
increased body weight. There are some disorders, 
which are associated with obesity; such are 
atherosclerosis, diabetes, non-alcoholic fatty liver 
disease and some types of cancer, which are leading 
causes of death in the USA [2]. 
 Some studies on GFM (germ-free mice) 
indicate that GFM are resistant to high-calorie foods 
and fattening besides feeding with high-calorie foods 
[3]. Colonisation the GFM with microbiota derived 
from "obese donor" results with an increase of the full 
body fat and body weight, backwards if GFM is 
colonised with microbiota derived from "slim donor", 
they won't get fat beside feeding with high-calorie 
foods [4]. GFM, which received faecal transplantation 
from “obese donor”, will increase their body weight [5]. 
All of these studies impose an opinion that the human 
gut microbiota may have a role in the development of 
obesity and obesity-associated disorders.  
 
 
Results 
 
 Composition and taxonomic distribution of 
 gut microbiota 
 Human Microbiome Project included 554 
individuals, selected by many criteria. The average 
age of them was 26, and the average Body Mass 
Index (BMI) was 24 kg/m
2
. Samples were collected 
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from 18 regions of the body and gut sample just from 
faeces [6]. Compositions of the microbiota were 
determined by 16S rRNA genetic sequencing 
performing metagenomics profiles of all sequenced 
genomes. All knowledge about gut microbiota was 
published in 2012 in two studies [7], [8]. The 
conclusion was that the healthy human gut microbiota 
consists of 70-100 known bacterial species [7]. 
However, 16S rRNA gene sequencing techniques 
guessed that the number of bacteria in the human gut 
microbiota might exceed 1000 species because of 
consisting some very rare, thin and non-cultivable or 
non-classified categories of bacteria [9].  
Table 1: Taxonomic review of the members of gut 
microbiota into divisions, classes, orders, families 
and species 
Division Class Order Family Species 
Firmicutes 
Clostridia Clostridiaels 
Clostridiaceae Clostridium 
Ruminococcaceae 
Ruminococcus 
Faecalibacterium 
Eubacteriaceae Eubacterium 
Bacilli Lactobacilliales 
Lactobacillaceae Lactobacillus 
Streptococcaceae 
Streptococcus 
Enterococcus 
Erysiphelotrichia Erysiphelotrichales Erysiphelotrichaceae 
Turicibacter 
Catenibacterium 
Coprobacillus 
Allobaculum 
Negativicutes 
Selemonadales Selenomonadaceae Megamonas 
Veillonellales Veillonellaceae 
Dialister 
Megasphaera 
Veillonella 
Bacteroidetes Bacteroidia Bacteroidales 
Prevotellaceae Prevotella 
Bacteroidaceae Bacteroides 
Actinobacteria 
Coriobacteria 
Coriobacteriales 
Coriobacteriaceae Collinsella 
Atopobiaceae Olsenella 
Egerthellales Eggerthellaceae 
Slackia 
Eggerthella 
Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium 
Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium 
Proteobacteria 
Gammaproteo- 
bacteria 
Enterobacteriales Enterobacteriaceae 
Escherichia 
Shigella 
Aeromonadales Succinivibrionaceae 
Succinivibrio 
Anaerobiospirillum 
 
 
 Oesophagus, stomach and small intestine 
 There are no data for permanent microbiota in 
the proximal part of the oesophagus. Studies have 
detected that in proximal oesophagus, the diversity of 
microbes is low. Studies for the distal part of the 
oesophagus say that there is reduced diversity and a 
dominant species of it is Streptococcus. Also, it is 
known that the reduced diversity of microbes in the 
oesophagus is good to sustain the wellbeing of the 
oesophagus [9]. The low pH of stomach limits many 
types of microbes, which get there. Attendance or 
absence of Helicobacter pylori affects the composition 
of the stomach microbiota. When H. pylori are there, it 
is a dominant species. Otherwise, Streptococcus is 
dominant [10]. H. pylori can be commensal or 
pathogen species of the stomach [4]. Besides this, 
stomach microbiota consists of other species as 
Prevotella, Veillonella and Rothia.  
 It is very hard to derive data about the 
microbiota in the small intestine because of 
insufficiency of healthy volunteers. Based on some 
routine microbiological examinations and molecular 
studies, it is known that Streptococcus is a dominant 
species in duodenum and jejunum. Generally, it is 
accepted that the diversity and complexity of bacterial 
communities increases in proximal-distal direction 
(from the duodenum to ileum). 
 
 Large intestine and faeces 
 The composition of microbiota in the large 
intestine is very similar to those in the distal part of the 
small intestine, actually ileum. It is much easier to 
examine the composition of the large intestine 
microbiota than other parts of the gut. Five divisions of 
bacteria are present; such are Firmicutes, 
Bacteroidetes, Actinobacteria, Fusobacteria and 
Proteobacteria. Divisions Firmicutes and 
Bacteroidetes are more numerous than the others. 
They take 90% of the number of all bacteria in the 
large intestine [9]. Less than 0.1% of human gut 
microbiota are some pathogens as Campylobacter 
jejuni, Salmonella enterica and Vibrio cholerae  
(Figure 1). 
 
Figure 1: Composition and number of major gut microbial species 
 
 Factors that influence the human gut 
 microbiota 
 The composition and count of gut microbiota 
are dynamic and variable, even under the subtle 
influences of some environmental factors [11]. Some 
of these factors are: 
 Genetics - Studies have revealed that host 
genetics has a small but statistically significant effect 
on the microbiota's composition and count. Studies on 
mice with variation in the MHC (Major 
Histocompatibility Complex) genes have shown that 
the host's genetics influences the microbiota. These 
mice had a higher susceptibility to autoimmune 
disease because of influences of the gut microbiota. 
 Age - There are some acknowledgements 
that the humans are exposed to microbes even during 
the intrauterine period, and there were identified 
bacterial DNA in healthy placentas, amniotic liquid 
and meconium of term newborns. The delivery mode 
(vaginal or cesarean section), the feeding style (breast 
milk or baby milk) are the main factors which 
determine the microbiota at newborns. During the first 
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three years of life, the microbiota of children is getting 
more numerous and more complex. 
 Diet - Food, which people eat, obtain 
nutrients for the host, but also the gut microbiota. This 
fact is remarkable at children who are weaning from 
baby milk and are starting to eat some different food, 
which is getting a low number of Bifidobacterium 
species in their intestines. Domination of gut bacteria 
which are metabolising vegetative polysaccharides 
(Roseburia, Eubacterium rectangle and 
Ruminococcus bromii) is marked in veggies. People 
who eat meat have bile-tolerant microbes; such are 
Alistipess, Bilophila and Bacteroides.  
 Drugs - As it is well known, all the 
medications affect the gut microbiota. The most 
studied affections are connected with the use of 
antibiotics. For example, during the treatment with 
Ciprofloxacin, which does not influence anaerobic 
bacteria, reduction of 1/3 of anaerobic gut bacteria 
may be detected. This effect is a result of the 
elimination of some basic bacterial species, which are 
necessary for the survival of the others. 
 
Figure 2: Main factors affecting the gut microbiota composition 
highlighting the great influence of diet and lifestyle on the 
composition 
 
 Lifestyle - Many everyday activities can affect 
the gut microbiota. For example, the microbiota on the 
skin and in the intestine are similar between family 
members, especially if they have a pet, which is some 
vector transferring microbes between family members. 
Also, travelling in different parts of the World derives 
variation in the gut microbiota, very similar to those of 
the domestic people. 
 Circadian rhythms - Period of the day, 
ambient of lights and temperature and food availability 
affects the human physiological processes and the 
human gut microbiota. Some oscillations in the 
microbiota in people, who work in shifts or work hard, 
can because of some metabolic disorders. 
 
 
Discussion 
 
 Dysbiosis  
 Dysbiosis is a condition, determined by 
quantitative and/or qualitative (functional) reduction of 
the composition of microbiota [12]. Dysbiosis has two 
main characteristics: 
 - Reduced diversity of microbial community 
against healthy individuals; 
 - Some degree of the inflammatory state, 
despite the primary process of the disease/condition. 
 Many daily activities, such as feeding style, 
hygiene habits, physical activity, medications, host 
genetics, living region, etc., probably cause dysbiosis. 
 
 Obesity 
 Malnutrition encompasses obesity and 
undernutrition are characterised by an imbalance 
between energy input and output. In 2014, 
assessments were about more than 600 million obese 
people, and more than one billion suffering from 
undernutrition [1]. The epidemic of obesity has spread 
in more than 1/3 of the elderly population, and the 
average costs for obesity treatment complications are 
1429 dollars higher than costs for slim people [2]. 
Data from National Health and Nutrition Examination 
Surveys point than 64% from elderly Americans (>20 
years old) was with BMI (Body Mass Index) higher 
than 25 between the years 1999-2000 [13].  
 Obesity is a condition of the excess of body 
fat and scarcely ever is a condition of higher body 
mass, because the body mass can be increased at 
people with higher muscle volume or women who are 
pregnant. Obesity-associated diseases, like 
atherosclerosis, diabetes, non-alcoholic liver disease 
and some kinds of cancer are the leading causes of 
death in the USA and the World [2]. Also, the 
distribution of body fat influences morbidity. For 
example, intra-abdominal and abdominal fatty tissue 
is more implicated in the initiation of obesity 
complications than the subcutaneous fatty tissue on 
the thigh and arm. 
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 Appetite control and energy balance 
 Body weight is controlled by endocrine and 
neural mechanisms, which influence the energy input 
and output. This complex regulatory system is 
essential because even small balance disorders lead 
to big bodyweight disturbances. By the weight loss, 
the appetite is getting up, and consumption of energy 
decreases, but this mechanism does not work very 
often. 
 The appetite is controlled by many factors, 
which are integrated into the central nervous system 
(CNS), rather the hypothalamus. Signals, which 
arrive, to the hypothalamus include afferent neural, 
hormone and metabolic signals. Neural signals are 
derived by the Vagus nerve, which is produced by the 
distension of the digestive system walls. Hormone 
signals include leptin, insulin, cortisol, ghrelin, peptide 
YY (PYY), cholecystokinin and some peptides from 
the digestive system. Also, a lot of physiological and 
culturally factors play a role in appetite control (Figure 
3). 
 
Figure 3: Factors that regulate appetite through effects on CNS. 
(NPY-neuropeptide Y; MCHmelanin-concentrating hormone; AgRP-
agouti-related transcript; MSH-melanocyte stimulating hormone; 
CART-cocaine and amphetamine-related transcript; GLP-1-
glucagon-like peptide; CCK-cholecystokinin; PYY-peptide YY) 
 
 Gut microbiota and appetite control 
 Gut microbiota is included in the regulation of 
food intake by the influence to the hormones, which 
regulate the metabolic function and some brain 
regions responsible for the food intake, also defined 
as gut-brain axis [1]. 
 The brain constantly comes up to different 
neural and hormone signals, which monitor the energy 
level in the body. Most of these signals are evolved in 
the gut and are part of the gut-brain axis. The axis is 
affected by the feeding style, genetics, anatomy of the 
gut and the gut microbiota. The food intake influences 
the releasement of some hormones and makes sense 
of fullness and appetite decrease. Distension of the 
stomach evolves Vagus nerve afferent signal to the 
brain (rhomb encephalon) and release of hormones 
from the stomach mucosa, such as CCK, GLP-1, PYY 
and leptin. All of these neural and hormone factors 
influence the gut-brain axis affecting the hypothalamic 
arcuate nucleus (Figure 4). 
 
Figure 4: Central hormonal control of appetite and energy 
expenditure. (NPY-neuropeptide Y; AgRP-agouti-related peptide; 
POMC-proopiomelanocortin; CART-cocaine and amphetamine-
related peptide; CCK-cholecystokinin; GLP-1-glucagon-like peptide; 
OXM-oxyntomodulin) 
  
 The hypothalamus plays the central role in the 
energy homeostasis by influencing appetite and 
energy consumption. Two different groups of neurons 
are responsible for the interpretation of the peripheral 
signals. Appetite suppressing neurons (anorexigenic), 
proopiomelanocortin (POMC) and cocaine and 
amphetamine-regulated transcript (CART) are located 
in the lateral part of the hypothalamic arcuate nucleus 
(Fig. 4) which expresses α-melanocyte stimulating 
hormone. Melanocortin and α-melanocyte stimulation 
hormone induce a negative energy balance. These 
peptides are synthesised because of the increase in 
fatty tissue. In the medial part of the hypothalamic 
arcuate nucleus are located the orexigenic neurons 
which express the neuropeptide Y (NPY) and agouti-
related protein (AGRP). NPY and AGRP are the main 
central neurotransmitters, which stimulate appetite 
and decrease energy consumption. 
 The gut microbiota composition and dysbiosis 
influence on the hormone orchestration and indirectly 
affect the appetite. Breton et al.,  [20] studied how the 
intestinal infusion of Escherichia coli proteins in mice 
affects the increase of plasmatic levels of GLP-1 and 
PYY. They found that the changes in the gut 
microbiota (dysbiosis) induced changes in the 
plasmatic levels of GLP-1 and PYY, which are 
hormones that affect the hypothalamic arcuate 
nucleus and the appetite.  
 Queipo-Ortuño et al., [21] studied the 
association between some genus from the gut 
microbiota and the plasmatic levels of ghrelin and 
leptin. They noticed that there is a significant positive 
correlation between the number of Bifidobacterium 
and Lactobacillus and a significant negative 
correlation between the genus Clostridium, 
Bacteroides and Prevotella with the plasmatic levels 
of leptin. Also, they noticed that the plasmatic levels of 
ghrelin are negatively correlated with the genus 
Bifidobacterium, Lactobacillus and B. coccoides and 
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positively correlated with Bacteroides and Prevotella 
(Table 2). 
Table 2: Relations between plasmatic levels of leptin and 
ghrelin with gut microbiota composition 
↑Leptin 
↑Lactobacillus and Bifidobacterium 
↓Prevotella and Clostridium 
↑Ghrelin 
↑Prevotella and Bacteroides 
↓Lactobacillus and Bifidobacterium 
 
 All these acknowledgements indicate that the 
differences in feeding style and physical activity 
influence the gut microbiota composition, affecting its 
diversity. Generally, the food restriction and increase 
of physical activity have a potentially negative 
influence on the number and composition of the 
intestinal bacteria, which are health promoters.  
 Generally, there is a trend of eating high-
calorie foods, which affect the gut microbiota. In a 
way, the gut microbiota is described as an 
environmental factor, which activity results with an 
increased depot of adipose tissue and obesity [1]. 
 In the past fifteen years, many scientists were 
exploring the association of the gut microbiota and 
some diseases, and the possibility for treatment 
affecting the gut microbiota. Conclusions from these 
studies resulted in inconsistent findings of the 
association between gut microbiota and obesity. The 
association was studied mainly on animal models. 
GFM (germ-free mice) are resistant to high-calorie 
food and high food intake, which by science are the 
main promoters of obesity. Additionally, colonisation 
of GFM with "obese gut microbiota" increased the 
fatty tissue and body weight, in contrast to 
colonisation with "slim gut microbiota" [14]. 
 Contact between microbes and the intestinal 
epithelial cells determine which signals are good and 
which are bad. Enhanced pilling up to energy by the 
"obese gut microbiota" is the most common 
explanation for obesity. Reduced number of the 
members of the division Bacteroidetes and 
proportionally increased number of the members of 
the division Firmicutes, which are associated with a 
bigger capacity to supply energy from food, such as 
degradation and fermentation to complex 
carbohydrates [15], characterise “obese gut 
microbiota”. 
 The "obese gut microbiota" has a bigger 
capacity to derive energy from the food, and to 
stimulate gene reprogramming in the large intestine, 
to change the secretion of polypeptide hormones and 
other bioactive molecules from enteroendocrine cells 
and too weak the defence and immunologic 
homeostasis in the intestine. The gut microbiota also 
communicates with the adipose tissue, the liver and 
the brain [16], (Figure 5). 
 Axis gut microbiota-adipose tissue: The 
gut microbiota is included in the regulation of adipose 
tissue through different mechanisms. LPS 
(lipopolysaccharide) incites immune response with 
inflammation and immune cells penetration in the 
adipose tissue. SCFAs (short-chain fatty acids) are 
included in insulin-related fat accumulation in the 
adipose tissue through activation of GPR43 and 
GPR41, which inhibit the lipolysis and enhance the 
differentiation of the adipose cells. 
 
Figure 5: Local and distant effects of gut microbiota in the 
pathogenesis of obesity [16]. (LPS-lipopolysaccharide; SCFAsshort-
chain fatty acids; Fiaf-fasting-induced adiposity factor; NKT-natural 
killer cell; GPR 43/41-G-protein-related receptor; AMPKAMP-
activated protein kinase; CHREBP-carbohydrate related element-
binding protein; SREBP-1-sterol regulating element-binding protein; 
FXR-farnesoid X receptor; TMAO-trimethylamine N-oxide; GLP-1-
glucagon-like peptide; PYY-peptide YY; CCK-cholecystokinin) 
 
 Axis gut microbiota-liver: Dysbiotic 
microbiota induces increased penetration at the 
intestinal mucosa for some pathogens and parts or 
metabolites from intestinal bacteria, such as LPS and 
ethanol. In the liver, LPS induces inflammation 
through stimulation the immune cells. Some 
metabolites as the bile acids, SCFAs and 
trimethylamine-N-oxide (TMAO) play a role in the 
pathogenesis of the non-alcoholic fatty liver disease 
(NAFLD). 
 Axis gut microbiota-brain: Afferent neurons 
from the digestive system and intestinal hormones are 
key signal molecules included in the communication 
between gut and brain and the metabolism of the 
host. Bioactive molecules which are included in the 
process are LPS, intestinal peptides, SCFAs, lactates 
etc. [16], (Figure 5). 
 Fiaf (Fasting-induced adipose factor) is a 
circulating inhibitor to the lipoprotein lipase, which is 
normally suppressed by the gut microbiota in the 
intestinal epithelium, and play a central role in the 
metabolism of triglycerides through inhibition the 
lipoprotein lipase production in the adipose tissue [3]. 
From this, it can be concluded that GFM are protected 
from obesity because of increased levels of Fiaf and 
Review Article 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
6                                                                                                                                                                                                   https://www.id-press.eu/mjms/index 
 
increased activity of AMPK (AMP-activated protein 
kinase). 
 Polypeptide hormones and other bioactive 
molecules released from enteroendocrine intestinal 
cells are included in the food intake regulation. 
Different TLRs (Toll-like receptors) expressed on 
enteroendocrine cells recognise different PAMPs 
(Pathogen-associated molecular patterns) and 
influence the polypeptide hormones release. For 
example, LPS from Gram-negative bacteria is 
recognised by TLR4 and induce secretion of CCK 
(satiety hormone) [16], which decrease the appetite 
and increases energy consumption [1].  
 Injured intestinal barrier and penetration of 
bacteria or bacterial products through the barrier is an 
important mechanism to the pathogenesis of obesity. 
Some bacterial products play a role in the regulation 
of the intestinal barrier, associated with SCFAs. Also, 
obesity is related to mild chronic inflammation, and 
some antigens from the gut may be inducers of this 
activity. Dysbiosis affects the innate and adaptive 
immunity through some microbe cell components and 
metabolic signals. 
 Besides the local influence, the gut microbiota 
influences distant organs, mainly the adipose tissue. 
Obesity is characterised by an increase of the volume 
of adipose tissue, and the gut microbiota enhances 
the mechanisms of metabolic disorders in the axis gut 
microbiota-adipose tissue. For example, LPS is 
identified as an inducing factor to the insulin 
resistance of the adipose tissue, which is transported 
to the adipose cells together with other lipoproteins 
through translocases. LPS-reach lipoproteins are 
absorbed by the bigger adipose cells, which has high 
metabolic activity. SCFAs synthesised by the gut 
microbiota participate in the insulin-mediated 
accumulation of lipids in the adipose cells, through 
activation of the SCFA-receptors (GPR43 and 
GPR41) which inhibits the lipolysis and induces 
differentiation of adipose cells. Mice with GPR43 
deficiency are obese besides the normal feeding, 
while the mice, which has a high expression of 
GPR43, are lean, besides feeding with high-calorie 
foods. GPR43 activation by SCFAs suppresses insulin 
signals to the adipose cells, which enhances the 
metabolism of lipids and carbohydrates in the other 
tissues. Suspect that GPR43 is a sensor for 
excessively receiving energy from the foods and keep 
the metabolic homeostasis [18]. A conclusion may be 
that GPR43 activation causes insulin resistance in the 
adipose tissue, but increased sensitivity in the 
muscles and the liver. 
 The liver is constantly exposed to signals by 
the digestive system, gut microbes and their particles. 
Alterations in the gut microbiota composition are firmly 
connected with risk for disorders in the liver 
associated with obesity, such as non-alcoholic fatty 
liver disease (NAFLD) [4]. The NAFLD severity is 
associated with the degree of dysbiotic gut microbiota, 
especially with the number of Bacteroidetes related to 
NAFLD and Ruminococcus related to liver fibrosis 
[19]. 
 Gut microbiota has a deep influence on the 
metabolism of bile acids through deconjugation, 
dehydrogenation and dihydroxylation of primary bile 
acids. Alteration in the gut microbiota gets changes in 
the bile-acid pool, which influences the nuclear 
antagonist of bile-acid X receptor (FXR) included in 
the regulation of bile acids, as the regulation of lipid 
and carbohydrate metabolism and may induce 
metabolic dysfunction, obesity and insulin resistance. 
 Also, Fiaf is included in the mechanisms 
which relate the gut microbiota and NAFLD, where the 
dysbiotic gut microbiota inhibits secretion of Fiaf from 
the intestinal cells and activates LPL, CHREBP and 
SREBP-1 and resulted in accumulation of triglycerides 
in the liver [3]. Ethanol and other bacterial products 
included in the NAFLD progression may be related to 
a high amount of alcohol producing bacteria from the 
Proteobacteria genus. 
 Gut microbiota has impinged upon distant 
organs and CNS, which recipes the abundance of 
neural and hormone signals from the digestive 
system. Bacteria and their metabolites may affect 
directly through vagus nerve stimulation or indirectly 
through immune-neuroendocrine mechanisms. Vagus 
nerve activation particularly is depended from the 
secretion of signal molecules as PYY, GLP- 1 and 
CCK. SCFAs is not just a source of energy, but also 
plays a role as a chemical transmitter [18]. 
 
 
Conclusion 
 
 Gut microbiota directly affects the metabolism 
of nutrients and vitamins, essential for the host 
organism. It is noted that the gut microbiota of obese 
people has a bigger capacity for getting energy from 
the food than the gut microbiota of lean people and 
the division Firmicutes is more effective in that. The 
gut microbiota is included in the control of appetite 
through hormones, which influence the metabolism 
and some parts of the brain responsible for the eating 
behaviour. Feeding style and physical activity affect 
the gut microbiota composition and its diversity - lower 
diversity relates to obesity. "Obese gut microbiota" 
has a lower number of members of the division 
Bacteroidetes and a high number of member of the 
division Firmicutes. Diet has maybe the biggest 
influence on the gut microbes, which is known through 
observation of the composition of microbiota after 
permanently taking some food. Undoubtedly, it may 
be concluded that the gut microbiota has a big 
influence in the pathogenesis of obesity and other 
obesity-related disorders. 
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